Clinical evaluation of drug-induced hepatitis
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To ascertain the epidemiological characteristics, clinical symptoms, and evolution of drug-induced hepatitis over the last 22 years. EXPERIMENTAL DESIGN AND SUBJECTS: An observational, retrospective study between 1982 and 1993, and prospective study between 1994 and 2003. All patients in our department diagnosed with having drug-induced hepatitis were studied analyzing epidemiological (age, sex, cases per year, hospitalization) and clinical features (previous liver disease, hepatic symptoms, laboratory results), and follow-up (complete recovery or chronicity). RESULTS: A total of 61 patients were diagnosed as having drug-induced hepatitis, 26 men and 35 women (57%), mean age 52.4 years +/- 17 years, of which 72.2% were older than 40 years. A total of 43% were admitted to hospital. In 87% of cases, two or more drugs were involved, the most frequent being antituberculosis (19 cases), psychotropic (26 cases), and non-steroidal anti-inflammatory drugs (45 cases). Evolution showed that 94% of patients recovered after the withdrawal of suspected causal drugs. CONCLUSIONS: The incidence of drug-induced hepatitis is higher in patients over 40 years of age, it being more common in females. Non-steroidal anti-inflammatory, psychotropic, and anti-tuberculosis agents were the main drugs involved. Most patients made a complete recovery after withdrawal of the suspected causal drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The diagnosis of DILI is one of exclusion, because it is not easy to define a toxic etiology as the cause of liver disease due to the heterogeneity of the clinical presentation and evolution.”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Drug-related hepatotoxicity is a common medical problem, with implications for health systems, and is also a cause of acute liver failure and, in many cases, responsible for the elimination of new pharmacological agents during efficacy and safety studies.”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [7]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Risk factors and pathogenesis of DILI are poorly understood.”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Incidence of drug-induced hepatic injuries: A French population-based study
Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 716
Drug–Induced Liver Injury: Mechanisms and Test Systems
Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.23505 · Cited by 267
Larrey, D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80417-1 · Cited by 253
Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
Lucena, M. I., Camargo, R., Andrade, R. J., Perez-Sanchez, C. J., & De La Cuesta, F. S. (2001) · Hepatology · doi:10.1053/jhep.2001.20645 · Cited by 212
FRIIS, H., & ANDREASEN, P. B. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00562.x · Cited by 150
Ibáñez, L., Pérez, E., Vidal, X., & Laporte, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00231-3 · Cited by 133
Antecedent liver disease and drug toxicity
Schenker, S., Martin, R. R., & Hoyumpa, A. M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80325-0 · Cited by 90
LEE, W. M. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00123.x · Cited by 88
Research works printed but not linked: 2
- [4]4. Sachs B, Haider S, Balaraman R, Shahab N, Perri MC. Hepatotoxici- ty of chemotherapy. Expert Opin Drug Saf 2002; 1: 339-53.
- [17]17. Contreras J, Poniachik J, Planzer M, Lazarte R, Smok G, Oksenberg R, et al. Drug induced liver disease: clinical and pathological pattern in 33 cases. Rev Med Clin 2003; 131: 1128-34.
Cited by
Drug-induced liver injury: Is it somehow foreseeable?
Tarantino, G., Minno, M. N. D. D., & Capone, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2817 · Cited by 137
Lewis, J. H., Ahmed, M., Shobassy, A., & Palese, C. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000218958.40441.fd · Cited by 66
Clinical characteristics of tuberculosis in patients with liver cirrhosis
Cho, Y., Lee, S., Yoo, C., Kim, Y. W., Han, S. K., Shim, Y.-S., & Yim, J. (2007) · Respirology · doi:10.1111/j.1440-1843.2007.01069.x · Cited by 62
Albendazole-induced granulomatous hepatitis: a case report
Marin Zuluaga, J. I., Marin Castro, A. E., Perez Cadavid, J. C., & Restrepo Gutierrez, J. C. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-201 · Cited by 45
Toxicidad hepática causada por medicamentos: revisión estucturada
Paniagua, A. C., Posada, L. M. C., & Amariles, P. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.177 · Cited by 40
Metadata
- Authors
- Martí, L., Olmo, J. A. D., Tosca, J., Ornia, E., García-Torres, M. L., Serra, M. A., Rodríguez, F., Lluch, P., Escudero, A., & Rodrigo, J. M.
- Affiliations
- Universitat de València (ES)
- Venue
- Revista Española de Enfermedades Digestivas
- Publisher
- SciELO Espana/Repisalud
- Published
- 2005-04
- Volume
- 97
- Issue
- 4
- Pages
- 258-65
- ISSN
- 1130-0108 (ISSN-L)
- OpenAlex
- W2122741469
- Cited by
- 14
- References
- 19
- Citations by year
- 2019: 2 · 2018: 1 · 2017: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Revista Española de Enfermedades Digestivas (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Hispana (submittedVersion, cc-by-nc)
- Scientific Electronic library online (Sciences Carlos III Health Institute) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced hepatitis, adverse drug reactions, nonsteroidal anti-inflammatory drugs, psychotropic drugs, antitubercular agents, drug withdrawal, clinical features
- MeSH terms
- Adult, Age Factors, Aged, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, Sex Factors, Spain, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical evaluation of drug-induced hepatitis. https://app.cochat.ai/papers/10.4321/s1130-01082005000400006
- The paper
- Martí, L., Olmo, J. A. D., Tosca, J., Ornia, E., García-Torres, M. L., Serra, M. A., Rodríguez, F., Lluch, P., Escudero, A., & Rodrigo, J. M. (2005). Clinical evaluation of drug-induced hepatitis. Revista Española de Enfermedades Digestivas. https://doi.org/10.4321/s1130-01082005000400006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
